Nervous System Infections Among Patients With Febrile Seizure

NCT ID: NCT01694524

Last Updated: 2014-05-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-06-30

Study Completion Date

2014-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Few studies dealing with the risk of infectious of nervous system and the utility of lumbar puncture and of emergent neuroimaging among patients with simple febrile seizure between 3 and 11 months age and with complex seizure has been reported. None of these studies was multicentric. Recommendations about management of these children are heterogeneous.

The investigators aim to study by an observational retrospective multicentric study the rate of infectious of central nervous system among patients with a complex febrile seizure and among patients between 3 and 11 months age with simple febrile seizure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Seizure Febrile Seizure Meningitis Encephalitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* febrile (\>38°)
* Seizure

Exclusion Criteria

* previous non febrile seizure
* known trauma
* immunodeficiancy status
* Underlying illness
Minimum Eligible Age

3 Months

Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hopital Universitaire Robert-Debre

OTHER

Sponsor Role collaborator

Hôpital Jean Verdier

OTHER

Sponsor Role collaborator

Centre Hospitalier Intercommunal Creteil

OTHER

Sponsor Role collaborator

Versailles Hospital

OTHER

Sponsor Role collaborator

Centre hospitalier Lagny Marne la vallée

UNKNOWN

Sponsor Role collaborator

Centre hospitalier intercommunal de Poissy

UNKNOWN

Sponsor Role collaborator

Hôpital Armand Trousseau

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

CARBAJAL

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ricardo Carbajal, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Hôpital Armand Trousseau, Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital Jean Verdier

Bondy, , France

Site Status

Centre hospitalier intercommunal de creteil

Créteil, , France

Site Status

Centre hospitalier Lagny-Marne la Vallée

Lagny-sur-Marne, , France

Site Status

Centre hospitalier de Versailles

Le Chesnay, , France

Site Status

Hôpital Armand Trousseau

Paris, , France

Site Status

Hopital Robert Debré

Paris, , France

Site Status

Centre hospitalier intercommunal de Poissy

Poissy, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

febrile seizure and infection

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.